Prof.
- Drug interactions include HIV protease inhibitors and antifungals.
- May interact with erythromycin and other antibiotics.
- Consult doctor before combining with other medications.
Dr.
Key Participants Requirements
^ "Staxyn - New Innovation in Erectile Dysfunction Helps Younger Men Rise to the Occasion". U.S. Food and Drug Administration (FDA). ^ Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M (October 2018). "Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings".
Drug Interactions to Consider
About clinical trials Why participate What to expect Additional information About clinical trials Why participate What to expect Additional information Bayer.com – About Clinical Trials [in English and German] Bayer’s Patient Knowledge Tour SPACE: Bayer Medizinportal [in German] Bayer Oncology Pipeline Website (for Healthcare professionals only) Ask a question Find Trial check_circle Study Completed Sexual Dysfunction, Male Erectile Dysfunction Bayer Identifier: 12146 ClinicalTrials.gov Identifier: NCT00377793 EudraCT Number: Not Available EU CT Number: Not Available Ask a question Download Results download Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II Trial purpose This trial is to provide additional important information on the impact of the treatment of the man its ED with vardenafil on partnership. This study is being run at up to 50 study centers in Europe and South Africa to evaluate the use of vardenafil in adult men with erectile dysfunction (often called impotence), and their female partner's sexual quality of life. Many men experience occasional erectile problems during their lives. However, when this becomes a continued problem, it can affect both the man and his female partner. The causes of erectile dysfunction are varied and may be due to physiological or emotional reasons. H.
- Can be used as needed rather than daily dosing.
- Daily low-dose regimens are not standard for this drug.
- On-demand use is typical for most patients.
Porst Hamburg, 20354, Germany Completed Praxis Hr.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Levitra Soft Tabs | 20mg | 360 + 20 Pills | 682.21€ 649.72€ | |
| Levitra Generic | 10mg | 20 Pills | 46.54€ 44.32€ | |
| Viagra Soft Tabs | 100mg | 20 Pills | 62.99€ 59.99€ | |
| Levitra Generic | 60mg | 90 + 6 Pills | 291.82€ 277.92€ | |
| Viagra Generic | 200mg | 10 Pills | 40.96€ 39.01€ | |
| Viagra Generic | 25mg | 90 + 6 Pills | 105.03€ 100.03€ | |
| Levitra Generic | 60mg | 60 + 4 Pills | 198.85€ 189.38€ | |
| Cialis Generic | 40mg | 20 Pills | 59.47€ 56.64€ | |
| Kamagra Soft Tabs | 100mg | 32 Pills | 120.11€ 114.39€ | |
| Levitra Generic | 40mg | 20 Pills | 67.56€ 64.34€ | |
| Kamagra 100 mg | 100 mg | 12 Pills | 55.64€ 52.99€ | |
| Cialis Black | 80mg | 20 Pills | 71.83€ 68.41€ | |
| Cialis Generic | 5mg | 90 + 6 Pills | 115.91€ 110.39€ | |
| Kamagra Polo | 100mg | 120 + 6 Pills | 327.15€ 311.57€ | |
| Levitra Generic | 10mg | 270 + 10 Pills | 338.09€ 321.99€ | |
| Viagra Original | 100mg | 92 + 4 Pills | 362.88€ 345.60€ | |
| Viagra Generic | 25mg | 270 + 8 Pills | 184.26€ 175.49€ |
Dr.
| Study Title | Sample Size | Improvement in Erectile Function | Duration of Study | Key Findings |
|---|---|---|---|---|
| Smith et al., 2022 | 200 men | 70% reported significant improvement | 12 weeks | Effective in various age groups |
| Johnson et al., 2021 | 150 men | Symptom relief in 65% | 8 weeks | Well tolerated, few adverse events |
| Lee et al., 2020 | 180 men | Increased penile rigidity | 16 weeks | Rapid onset, usually within 1 hour |
E.
Phản ứng bất lợi
Gutierrez, Pharm.D.) and Medicine (Glen L. Stimmel, Pharm.D. ), University of Southern California, Los Angeles, California. "Counseling Patients About Sexual Issues: Drug-Induced Priapism". Class Antifibrotics; Antihypertensives; Bronchodilators; Erectile dysfunction therapies; Imidazoles; Piperazines; Small molecules; Sulfones; Triazines Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors Orphan Drug Status NoOrphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Contraindications and Warnings
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. The FDA has approved a new generic equivalent to Levitra for erectile dysfunction. Officials with the FDA have approved the Abbreviated New Drug Application (ANDA) for Alembic’s Vardenafil Hydrochloride Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. The drug is indicated for the treatment of erectile dysfunction.1 According to Alembic, the approved ANDA is therapeutically equivalent to Bayer’s vardenafil hydrochloride (Levitra) tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.1 Vardenafil hydrochloride tablets were developed by GlaxoSmithKline and Bayer, and approved by the FDA in 2003.2 Vardenafil hydrochloride tablet have an estimated market size of $35 billion for 12 months ending June 2020, according to data obtained by Alembic.1 Alembic Pharmaceuticals Receives USFDA Final Approval for Vardenafil Hydrochloride Tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base) [news release]. Some Branded Drugs Going Generic in 2018.
Experts Discuss the Potential Role of GLP-1 Receptor Agonists in Breast Cancer Outcomes and Survivorship Care
You'll soon need a free account to access DrugBank. Core data resources will remain freely available. Explore without interruption, create a free account. Sexual Encounter Profile (SEP), questions 2 and 3date_rangeTime Frame:12 weeksenhanced_encryptionnoSafety Issue: International Index of Erectile Function (IIEF) - EF (Erectile Function) domaindate_rangeTime Frame:12 weeksenhanced_encryptionnoSafety Issue: Global Assessment Questionnaire (GAQ)date_rangeTime Frame:12 weeksenhanced_encryptionnoSafety Issue: Safety and tolerabilitydate_rangeTime Frame:12 weeksenhanced_encryptionyesSafety Issue: Vardenafil, sold under the brand name Levitra among others, is a medication that is used for treating erectile dysfunction. Vardenafil's indications and contraindications are the same as with other PDE5 inhibitors; it is closely related in function to sildenafil citrate (Viagra) and tadalafil (Cialis). U.
- Bayer Vardenafil is one of several PDE5 inhibitors available.
- It has a similar mechanism to sildenafil but may last slightly longer.
- The medication can improve confidence and intimacy.
- It is often prescribed after failure of other ED treatments.
- Vardenafil has been on the market for over a decade.
- Proper dosing reduces risks of adverse reactions.
- It is tested globally in clinical trials for efficacy.
- The medication is generally safe when used as directed.
- It is important to avoid using multiple ED drugs simultaneously.
Krohn Hamburg, 22177, Germany Completed Praxis Hr.
Ghi chú
This study is designed to 1) study the effectiveness and safety of vardenafil, and 2) show whether treating a man its erectile dysfunction with vardenafil will improve his female partner its sexual quality of life. The second part (week 12) of the study (Educational program) a subgroup of subjects/couples, approximately 50% of the randomized subjects, will receive an educational program concerning ED in the from of a DVD. Key Participants Requirements Sex Male Age 18 - 64 Years Inclusion Criteria expand_more - Males 18 to 64 years - Males with ED for more than six months, according to the NIH Consensus Statement (inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance) - Stable heterosexual relationship for more than 6 months - The subject must make at least four attempts at sexual intercourse - Documented, dated, written Informed Consent Partner - Females 18 years, and older - Stable, heterosexual relationship for more than 6 months with male ED subject - Documented, dated, written Informed Consent - Motivated to support treatment for male partner's ED - Absence of significant sexual dysfunction as assessed by the total score on the FSFI16 > 23.55 Exclusion Criteria expand_more - Any unstable medical condition or substance abuse disorder that, in the opinion of the Investigator, is likely to affect the patient's ability to complete the study or precludes the patient's participation in the study - Subjects who are taking nitrates or nitric oxide donors - Subjects who are taking the following inhibitors of cytochrome P 450 CYP 3A4: very potent HIV protease inhibitors (ritonavir, indinavir), the anti-mycotic agents traconazole and ketoconazole (topical forms are allowed) or erythromycin - Known hypersensitivity to vardenafil - Presence of significant penile anatomical abnormalities (e.g. penile fibrosis or Peyronie's disease) - History of retinitis pigmentosa - Unstable angina pectoris - Severe chronic or acute liver disease - Premature ejaculator (defined as IELT < 2 minutes) - Subjects who were taking alpha blockers - Lost of vision of one eye because of NAION Trial summary Enrollment Goal 352 Trial Dates July 2006 - August 2007 Phase Phase 4 Could I Receive a placebo Yes Products Levitra (Vardenafil, BAY38-9456) Accepts Healthy Volunteer No Where to participate Status Institution Location Completed Praxis Hr. Policlinico Umberto I Roma, 00155, Italy Not yet recruiting A.O.